Trulicity is a prescription medication used to manage type 2 diabetes in adults and children aged 10 and older. It belongs to a class of drugs called GLP-1 receptor agonists, which mimic a natural hormone your body produces after eating. Beyond blood sugar control, Trulicity also carries a separate FDA approval to lower the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes who have heart disease or multiple risk factors for it.
How Trulicity Works
After you eat, your gut releases a hormone called GLP-1 that signals your body to handle the incoming sugar. Trulicity mimics that hormone, but in a longer-lasting form that stays active for about a week. It works through three main pathways: it prompts your pancreas to release more insulin when blood sugar rises, it dials back a second hormone (glucagon) that tells your liver to dump stored sugar into your bloodstream, and it slows the rate at which food leaves your stomach. That last effect means glucose enters your blood more gradually after meals, and it also tends to reduce appetite.
Blood Sugar Control
The core job of Trulicity is lowering A1C, the measure of average blood sugar over roughly three months. In a real-world study following patients for two years, people taking Trulicity continuously saw their A1C drop by an average of 1.3 percentage points. By the 24-month mark, 43% of patients had reached an A1C below 7%, a common treatment target, and 73% were below 8%.
Higher doses produce larger reductions. In a clinical trial comparing different strengths, the 1.5 mg dose lowered A1C by 1.5 points, the 3.0 mg dose by 1.7 points, and the 4.5 mg dose by 1.9 points after 36 weeks. Those effects held steady through 52 weeks of follow-up.
Cardiovascular Protection
Trulicity’s second approved use is reducing the risk of serious cardiovascular events in adults with type 2 diabetes. This approval came from a large trial called REWIND, which tracked thousands of participants over several years. The results: Trulicity 1.5 mg reduced the combined risk of cardiovascular death, nonfatal heart attack, and nonfatal stroke by 12% compared to placebo. The benefit applied both to people who already had established heart disease and to those who hadn’t yet had a cardiac event but carried multiple risk factors like high blood pressure, high cholesterol, or a history of smoking.
Current guidelines from the American Diabetes Association reflect this evidence. For people with type 2 diabetes who have cardiovascular disease or are at high risk for it, the 2024 ADA guidelines recommend including Trulicity (or certain related medications) in the treatment plan regardless of whether the person is already on metformin or how well their blood sugar is controlled. The cardiovascular benefit is considered a reason on its own to use the drug.
Weight Loss Effects
While Trulicity is not approved as a weight loss medication, most people taking it do lose some weight. In clinical trials, the 1.5 mg dose led to an average loss of about 6.8 pounds, the 3.0 mg dose about 8.8 pounds, and the 4.5 mg dose about 10.4 pounds over 36 weeks. This weight reduction comes largely from the slowed stomach emptying and reduced appetite that GLP-1 receptor agonists produce. For people with type 2 diabetes who are also trying to manage their weight, this is often a welcome side effect rather than the primary goal of treatment.
How You Take It
Trulicity comes as a prefilled pen that you inject under the skin once a week. You can give yourself the shot at any time of day, with or without food, as long as you pick roughly the same day each week. The starting dose for both adults and children 10 and older is typically 0.75 mg per week, which your prescriber may increase based on how well your blood sugar responds. The maximum dose is 4.5 mg per week.
Common injection sites include the stomach, thigh, or upper arm. You rotate the site each week to avoid skin irritation. The pens need to be stored in a refrigerator between 2°C and 8°C (about 36°F to 46°F). If refrigeration isn’t available, a pen can stay at room temperature (below 30°C or 86°F) for up to 14 days. Never freeze the pen or use one that has been frozen. Used pens go into a sharps container, not regular trash.
Common Side Effects
The most frequent side effects are digestive. Nausea is the one people notice first, especially when starting treatment or moving to a higher dose. It tends to ease after the first few weeks as your body adjusts. Diarrhea, vomiting, stomach pain, and decreased appetite also occur. These effects are tied directly to how the drug works: slowing stomach emptying can cause that “too full” feeling or mild nausea, particularly after larger meals. Eating smaller portions and avoiding very fatty or greasy foods helps many people manage these symptoms while their body adapts.
Important Safety Concerns
Trulicity carries a boxed warning, the most serious type of safety alert, related to thyroid tumors. In animal studies, drugs in this class caused thyroid tumors, including a type called medullary thyroid carcinoma. It is not known whether Trulicity causes these tumors in humans, but the drug is off-limits for anyone with a personal or family history of medullary thyroid carcinoma or a rare condition called Multiple Endocrine Neoplasia syndrome type 2.
If you notice a lump or swelling in your neck, difficulty swallowing, hoarseness, or shortness of breath while taking Trulicity, those symptoms deserve prompt medical attention. Trulicity is also not appropriate for treating type 1 diabetes and should not be used as a substitute for insulin in people who need it.
Where Trulicity Fits in a Treatment Plan
For straightforward blood sugar management without cardiovascular concerns, metformin remains the usual first-line drug. Trulicity often enters the picture when metformin alone isn’t enough to reach A1C targets, or when a prescriber wants to address cardiovascular risk at the same time. The 2024 ADA guidelines are notable for recommending GLP-1 receptor agonists like Trulicity even as a first addition to treatment (or alongside metformin from the start) when heart disease or kidney disease is present. For people with chronic kidney disease who cannot tolerate another class of diabetes drugs called SGLT-2 inhibitors, Trulicity is listed as an alternative with proven cardiovascular benefit.
Trulicity can be used alone or combined with other diabetes medications, including insulin. Your prescriber will typically adjust doses of other drugs when adding Trulicity, especially if you’re on insulin or medications that can cause low blood sugar, since the combined effect can push glucose levels lower than expected.